Please use this identifier to cite or link to this item: http://dx.doi.org/10.25673/121509
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHund, Inga-
dc.contributor.authorHess, Maria Elena-
dc.contributor.authorAndrieux, Geoffroy-
dc.contributor.authorStomper, Julia-
dc.contributor.authorGreve, Gabriele-
dc.contributor.authorNiemöller, Christoph-
dc.contributor.authorMa, Tobias-
dc.contributor.authorUhl, David-
dc.contributor.authorGrishina, Olga-
dc.contributor.authorThol, Felicitas-
dc.contributor.authorHeuser, Michael-
dc.date.accessioned2025-12-01T11:57:47Z-
dc.date.available2025-12-01T11:57:47Z-
dc.date.issued2025-
dc.identifier.urihttps://opendata.uni-halle.de//handle/1981185920/123462-
dc.identifier.urihttp://dx.doi.org/10.25673/121509-
dc.language.isoeng-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subject.ddc610-
dc.titleGenetic and epigenetic alterations at secondary resistance after continued decitabine-based treatment of acute myeloid leukemia in the randomized phase II DECIDER trialeng
dc.typeArticle-
local.versionTypepublishedVersion-
local.bibliographicCitation.journaltitleLeukemia-
local.bibliographicCitation.volume39-
local.bibliographicCitation.issue11-
local.bibliographicCitation.pagestart2816-
local.bibliographicCitation.pageend2819-
local.bibliographicCitation.publishernameSpringer Nature-
local.bibliographicCitation.publisherplaceLondon-
local.bibliographicCitation.doi10.1038/s41375-025-02780-7-
local.openaccesstrue-
dc.identifier.ppn1940723981-
cbs.publication.displayform2025-
local.bibliographicCitation.year2025-
cbs.sru.importDate2025-12-01T11:57:30Z-
local.bibliographicCitationEnthalten in Leukemia - London : Springer Nature, 1997-
local.accessrights.dnbfree-
Appears in Collections:Open Access Publikationen der MLU

Files in This Item:
File Description SizeFormat 
s41375-025-02780-7.pdf1.48 MBAdobe PDFThumbnail
View/Open